HomeESPR • NASDAQ
add
Esperion Therapeutics Inc
Nakaraang pagsara
$1.02
Sakop ng araw
$1.01 - $1.03
Sakop ng taon
$0.69 - $3.94
Market cap
202.16M USD
Average na Volume
4.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 65.00M | -52.81% |
Gastos sa pagpapatakbo | 43.00M | 2.40% |
Net na kita | -40.46M | -166.30% |
Net profit margin | -62.24 | -240.50% |
Kita sa bawat share | -0.21 | -161.76% |
EBITDA | -22.07M | -130.52% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 114.63M | -49.41% |
Kabuuang asset | 324.03M | -13.14% |
Kabuuang sagutin | 750.24M | 12.42% |
Kabuuang equity | -426.21M | — |
Natitirang share | 198.20M | — |
Presyo para makapag-book | -0.47 | — |
Return on assets | -16.54% | — |
Return on capital | -29.84% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -40.46M | -166.30% |
Cash mula sa mga operasyon | -22.63M | -142.04% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | -7.50M | -108.28% |
Net change in cash | -30.13M | -120.87% |
Malayang cash flow | -18.77M | -201.63% |
Tungkol
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
Itinatag
May 1998
Website
Mga Empleyado
304
